Xenios wins CE Mark for I-Cor cardiac assist device
Xenios said yesterday that it won CE Mark approval in the European Union for its I-Cor synchronized cardiac assist device, touting it as the world’s 1st “heartbeat-synchronized” cardiac assist for cardiogenic shock and high-risk interventions. Heilbronn, Germany-based Xenios, which claimed in September to have drummed up an 8-figure funding round, said the I-Cor system is designed to provide “beat-to-beat” cardiac assistance using a miniature pump “with synchronized pulses that are superimposed over the patient’s weakened heartbeats.” “European regulatory approval o...
Source: Mass Device - November 25, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiac Assist Devices Regulatory/Compliance CE Mark XENiOS AG Source Type: news

Xenios claims ‘significant’ 8-figure funding round
Lung and heart therapy device developer XENiOS AG said today it received a “significant” round of funding, claiming the amount was in the 8-figure range. The Heilbronn, Germany-based company is developing a minimally invasive combined lung and heart therapy device on a single platform. “No other company except XENiOS is offering minimally invasive disposable lung and heart therapies on 1 platform. The XENiOS platform provides fundamental advantages with its minimally invasive lung and heart therapies. Patients are awake and mobile. Self-determined patients facilitate improved outcomes. There is no venti...
Source: Mass Device - September 23, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Assist Devices Cardiovascular Respiratory XENiOS AG Source Type: news

XENiOS(R) Receives Cash Infusion from Existing Investors to Expand Commercial Operations in US and Europe
HEILBRONN, Germany--(Healthcare Sales & Marketing Network)--XENiOS® AG a commercial-stage medical device company, announced today that it has received a significant cash infusion from existing investors. While the amount of investment was not disclosed... Devices, Venture CapitalXENiOS, novalung, Chronic Obstructive Pulmonary Disease
Source: HSMN NewsFeed - September 23, 2015 Category: Pharmaceuticals Source Type: news

Professor Jon Keating appointed new Chair of Heilbronn Institute
Professor Jon Keating has been appointed Chair of the Heilbronn Institute for Mathematical Research, which celebrates its ten-year anniversary in October this year.
Source: University of Bristol news - August 24, 2015 Category: Universities & Medical Training Tags: Announcements, Research; Faculty of Science, Faculty of Science, School of Mathematics Source Type: news

Burns in the head and neck: a national representative analysis of emergency department visits - Heilbronn CM, Svider PF, Folbe AJ, Shkoukani MA, Carron MA, Eloy JA, Zuliani G.
OBJECTIVES/HYPOTHESIS: Head and neck burns (HNBs) engender serious sequelae including airway edema, speech/swallowing dysfunction, sensory deficits, and scarring/disfigurement, often requiring significant reconstructive surgery. We used a nationally repres...
Source: SafetyLit: All (Unduplicated) - February 7, 2015 Category: Global & Universal Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Pages: 1  2